• Press kit
  • Contact
    • Privacy Policy
Invent Medic
  • Home
  • About Invent Medic
    • Vision & business activities
    • Business model
    • Product development
    • International outreach
    • History
    • Management team
    • Intellectual property
    • Join our team
  • Products and Brands
    • Efemia
    • International target group
    • Long-term customer relations
    • Studies with Efemia
    • Where to purchase Efemia
  • Investor Information
    • Press releases
    • Financial information
    • The Share
    • Newsletter
    • Presentations/films
    • Financial calendar
    • Corporate Governance
      • Board of Directors
      • Annual General Meetings
      • Auditor
      • Regulatory documents
Select Page
Regulatory

Invent Medic’s product Efemia bladder support included in Swedish online pharmacy Apotea’s assortment

Published the 3 July 2020Invent Medic announces that the company has signed an agreement with the Swedish online pharmacy Apotea for the inclusion of the product Efemia bladder support in Apotea’s assortment. Efemia will become available to buy on apotea.se during the summer. With this...
Download: Release
Read more

Invent Medic publishes newsletter highlighting early signs of a normalisation in the European healthcare systems

Published the 18 June 2020Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties. In this issue, CEO Karin Bryder informs that ongoing procurement processes and negotiations with Swedish healthcare regions continued...
Download: Release
Read more

Invent Medic’s product Efemia bladder support approved for prescription with cost coverage in England

Published the 6 May 2020Invent Medic announces that the company’s distributor has signed an agreement with NHS England, which means that the product Efemia bladder support can be prescribed with cost coverage in England from April 11, 2020. Efemia was launched in the UK in late 2019 together...
Download: PM England prescription Efemia
Read more

Invent Medic publishes newsletter highlighting that Efemia will soon become available to buy in 33 of Apoteket AB’s pharmacies in Sweden

Published the 4 May 2020Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties. In this issue, CEO Karin Bryder comments on that Apoteket AB will begin to offer the company’s product Efemia Bladder Support at 33...
Download: Release
Read more
Regulatory

Annual Report 2019 and Decision Documents for the Annual General Meeting 5 May 2020

Published the 14 April 2020Invent Medic Sweden AB today presents the Annual Report for 2019 and the Proposal for Decision for the upcoming Annual General Meeting on May 5, 2020 in Lund. CEO Karin Bryder summarises the year 2019 was characterised by a commercial breakthrough for Invent Medic’s...
Download: Release
, Proposal for decision 05-05-2020
, Invent Medic Annual Report 2019
Read more

Invent Medic publishes newsletter with CEO interview on the company’s ongoing share issue and progress in the beginning of 2020

Published the 25 February 2020Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties. In this issue, CEO Karin Bryder comments on the company’s ongoing share issue for a continued aggressive international expansion with...
Download: Release
Read more
« Older Entries
Next Entries »
AllRegulatory posts

Copyright © 2025 Honeybadgers|Developed by Honeybadgers|Proudly powered by WordPress